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Background: Onchocerca lupi, a filarioid of zoonotic concern, infects dogs and cats causing ocular lesions of
different degrees, from minor to severe. However, infected animals do not always display overt clinical signs,
rendering the diagnosis of the infection obscure to the majority of veterinarians. Canine onchocercosis has been
reported in the Old World and the information on its occurrence in the United States, as well as its pathogenesis
and clinical management is still meagre. This study reports on the largest case series of O. lupi infection from the
United States and reviews previous cases of canine onchocercosis in this country.
Methods: Information on the clinical history of a series of eight cases of O. lupi infection in dogs diagnosed in
Minnesota, New Mexico, Colorado and Florida, from 2011 to 2014, was obtained from clinical records provided the
veterinary practitioners. Nematodes were morphologically identified at species level and genetically analyzed.
Results: All dogs displayed a similar clinical presentation, including subconjunctival and episcleral nodules, which
were surgically removed. Each dog was subjected to post-operative therapy. Whitish filaria-like parasites were
morphologically and molecularly identified as O. lupi.
Conclusions: This study confirms that O. lupi is endemic in the United States, indicating that the distribution of the
infection is probably wider than previously thought. With effect, further studies are urgently needed in order to
improve the diagnosis and to assess the efficacy of therapeutic protocols, targeting the parasite itself and/or its
endosymbionts.
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Some filarioids (Spirurida, Onchocercidae) represent a
major threat for human health, causing debilitating and
socially stigmatizing life-threatening conditions, mainly
in developing countries [1]. This is the case of Wuchereria
bancrofti and Onchocerca volvulus, the agents of human
lymphatic filariasis and river blindness, respectively, which
are included in the WHO's priority list of the neglected
tropical diseases [2,3]. Meanwhile, human infections by
zoonotic filarioids are being more and more often re-
ported worldwide [4], due to a plethora of environmental* Correspondence: domenico.otranto@uniba.it
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unless otherwise stated.and anthropic factors allowing the spreading of arthropod
vectors [5,6]. This has been recognized for the canine
Dirofilaria immitis and Dirofilaria repens, whose mos-
quito vectors are prevalent in the same environments
[5,7,8]. The role of dogs as reservoir hosts for zoonotic
nematodes has spurred the interest of the scientific com-
munity towards the study of other species, which may
parasitize domestic animals [4]. For example, Onchocerca
lupi infects the ocular tissues of dogs and cats [9,10]
causing from minor to severe ocular lesions [9,11]. In the
initial stage, canine onchocercosis is associated with
nonspecific ocular discomfort (i.e., excessive lacrimation,
photophobia, conjunctivitis, exophthalmos and periorbital
swelling) [9,12,13], while, in the chronic phase the typical
nodules are detected on the external parts of the ocularl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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[9,14,15]. However, dogs do not always display overt clin-
ical signs if O. lupi adults develop in the retrobulbar space
of the eye [11,13]. Accordingly, the diagnosis of O. lupi re-
lies on the detection of microfilariae in skin snips [16] and
may also be investigated by the use of imaging tools (i.e.,
ultrasound scans, computed tomography) [14].
In the United States, cases of canine onchocercosis
have been reported since the 90s in California, Utah and
Arizona [17-19] but nematodes were not identified at
species level. The tentative identification of the parasites
in the cases above as Onchocerca lienalis has been ques-
tioned [12] based on the following circumstantial evi-
dence: i) the site of the infection (i.e., filarioids were
detected in the ocular region while O. lienalis localizes
to the gastro-splenic ligament area of cattle); ii) the fail-
ure of experimental infection of dogs with this filarioid
species [12]. In addition, the occurrence of gravid female
nematodes in the patients above suggested that dogs
were most likely the primary/proper host for those para-
sites, as is the case for O. lupi. The morphological and
molecular identification of O. lupi in dogs and cats from
the southwestern states (i.e., Colorado, California, Utah,
Nevada) [10,20,21] raised the hypothesis that this parasite
was implicated also in the cases above. Finally, the first
zoonotic case of O. lupi in Arizona [21] has renewed the
interest about this parasite, which has also been increas-
ingly found in humans in the Old World [22-25].
The information on the pathogenesis of canine oncho-
cercosis is still minimal and little data is available on the
clinical management of O. lupi. Therefore, this article
documents the clinical presentation and the treatment
of a series of recently reported cases of canine onchocer-
cosis from the Unites States (i.e., Minnesota, New
Mexico, Colorado and Florida) [26], along with a review
of canine onchocercosis in this country.
Methods
Clinical history and case outcome
Information on the clinical history of a series of eight cases
of O. lupi infection in dogs diagnosed in the Minnesota,
New Mexico, Colorado and Florida, from 2011 to 2014,
was obtained from clinical records provided by the veter-
inary practitioners in charge for each case. Information on
treatment and case outcome was also provided. All med-
ical procedures were performed after obtaining the owner
consent.
Cases on canine onchocercosis diagnosed in the United
States, published in the literature were also reviewed. In
particular, data on the sex, age, geographical origin, travel
history, localization of the nodules and parasite identifica-
tion for each individual case was analyzed from articles
published in the international literature, from 1991 to
2014 [12,17-20,26].Morphological and molecular identification
Nematodes collected were morphologically identified at
species level based on [27] and [22]. In addition, specimens
extracted from dogs 2 and 3 were molecularly processed.
Following the genomic DNA extraction by DNeasy Blood
& Tissue Kit (Qiagen, GmbH, Hilden, Germany), partial
cytochrome oxidase subunit 1 (cox1) and 12S rDNA genes
were amplified and sequenced as described elsewhere [22].
Results
Clinical history and case outcome
Case 1
An 8-year-old female dog, rescued in Hollywood (Florida)
on June 2014, was presented to a local ophthalmologist
due to the onset of conjunctival granulomas, which were
surgically removed and histologically examined. The ani-
mal was treated for heartworm with ivermectin (400 μg/kg
orally every day, for 30 days) and fenbendazole (100 mg/kg
orally once daily). A few months later, conjunctival lesions
reoccurred OU and the animal underwent a second sur-
gery during which nematodes were extracted. Samples
were sent to Cornell University to be morphologically and
molecularly identified. A gravid female worm was mor-
phologically identified as Onchocerca sp. and microfilariae
sent to the Centers for Disease Control and Prevention
(CDC; Atlanta, GA, USA).
Case 2
A 7-year-old castrated mixed breed male dog from Oro-
noco (Minnesota) presented at the BluePearl Veterinary
Partners hospital in Eden Prairie (Minnesota) with a 1-
year history of red eyes that worsened into proliferative
ocular lesions on the medial aspects of the globes OU.
The owners reported that their pet was adopted one year
before from the municipality of Durango (Colorado) and
that it suffered mild scleritis. At the ophthalmic examin-
ation, both eyes appeared similar with two pink subcon-
junctival masses. The first (5 mm in diameter) was located
immediately posterior to the nasal limbus, and the second,
less dense, was located approximately 3 mm posterior to
the temporal limbus (Figure 1A). Since the administration
of ivermectin (450 μg/kg orally once daily), fenbendazole
(100 mg/kg orally once daily), and corticosteroids did not
resolve the ocular lesions, surgical excision of the masses
was undertaken. Whitish filaria-like parasites were re-
moved from the sites, the majority of which were embed-
ded within the bulbar conjunctiva, sclera and extraocular
muscles (Figure 1B). Post-operative therapy included cef-
podoxime (5 mg/kg orally once daily for 10 days), carpro-
fen (2.2 mg/kg orally twice daily for 5 days then once daily
for 5 days), and tramadol (2 mg/kg orally one to three
times daily), as well as ivermectin (600 μg/kg orally) and
fenbendazole (100 mg/kg orally) both once daily for
8 weeks. The eyes were reportedly normal with no
Figure 1 Ophthalmic examination of dog 1 with subconjunctival masses containing convoluted nematodes (A); surgical removal of the
nematodes (B).
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operative follow-up and four months of post-operative
contact with the primary veterinarian and owners.
Case 3
A 6-year-old neutered female Labrador retriever mix dog
was presented on March 2014 at the Veterinary Specialty &
Emergency Hospital in Englewood (Colorado). The animal
displayed a red swollen left eye (Figure 2), with squinting
and tearing from both eyes. The patient was originally from
Farmington (New Mexico) and suffered from red tearing
eyes in the past. The animal was heartworm antigen nega-
tive. During the ophthalmic examination, episcleral swelling
and episcleral vascular congestion was reported in the tem-
poral quadrant OS, as well as scleral indentation of the
temporal fundus. Whitish nematodes were detected during
the incisional biopsy and stored in 70% ethanol, to be mor-
phologically and molecularly identified. An oral treatmentFigure 2 Ophthalmic examination of dog 2. Red swollen left eye.with doxycycline (10 mg/kg orally once daily for three
months) and ivermectin (400 μg/kg orally once daily for
two months then sporadically for a total of five months)
was undertaken. The animal was re-examined 6 months
after and a complete resolution in the ocular discomfort
was recorded.
Case 4
A 2-year-old female mix breed was examined on June
2014. The dog was originally from Farmington (New
Mexico), where she was adopted about six weeks before.
The animal was apparently healthy, apart for a slight
squinting and disconformity in the size of the eyes. The
animal was heartworm antigen negative. At the ophthal-
mic examination, the eyes presented numerous inflamma-
tory conjunctival follicles, mild epiphora, mild diffuse
conjunctival hyperemia and soft episcleral swellings in the
temporal quadrant, larger in the right eye. During the inci-
sional biopsy, some nematodes were detected and ex-
tracted. Oral treatment with ivermectin (400 μg/kg orally
once a month for six months) and doxycycline (100 mg/kg
orally once daily for three months) was performed. The
animal was followed-up three months later and did not
show any relapse.
Case 5
A 3-year-old neutered male Labrador retriever mix dog
was presented on October 2012 with a complaint of recent
conjunctivitis in both eyes. The animal was rescued from
an animal shelter in Farmington (New Mexico), approxi-
mately one year before. At the presentation, no blepharo-
spasm or significant conjunctival hyperemia were observed
but large subconjunctival granulomas (Figure 3A), contain-
ing multiple intertwined white thread-like nematodes,
were noted in the dorsal bulbar region in both eyes. The
animal underwent preoperative treatment with moxydec-
tin (0.22 mg/kg subcutaneously), prednisone (0.5 mg/kg
Figure 3 Ophthalmic examination of dog 3. Evident episcleral nodule (A) and nematodes extracted during the incisional biopsy (B).
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and neopolydex in both eyes. Subconjunctival exploratory
surgery was performed one week later (Figure 3B) and
nematodes were extracted. Following the surgery, melarso-
mine (2.5 mg/kg intramuscular) was administered in the
lumbar epaxial muscle and the patient was treated with
prednisone (0.5 mg/kg orally twice daily for one week fol-
lowing exploratory, tapered to once daily), doxycycline
(5 mg/kg orally twice daily) and neopolydex in both eyes,
three times daily. The animal was heartworm antigen
negative. Post-operative recheck examinations were per-
formed once each month for four months; at each examin-
ation during this four-month period, an injection of
moxydectin (0.22 mg/kg subcutaneously) was given. At the
end of this four-month period, prophylactic oral antihel-
mintic therapy was initiated at 400 μg/kg orally every day
for 30 days. Recheck examinations were again performed
at six months and at one year. No further instances of
episcleral masses were noted.
Case 6
A 3-year-old neutered male Yorkshire terrier dog from
Farmington (New Mexico) was presented on May 2014
due to moderate chemosis and to an episcleral flocculent
mass in the lateral portion in the right eye. The animal
was heartworm antigen negative. A subconjunctival ex-
ploratory was performed and multiple thread-like nema-
todes were removed from the episcleral region in the
right eye. The animal underwent the same therapeutic
protocol and recheck examinations of case 4, being com-
pletely healthy at each follow-up.
Case 7
A 9-year-old neutered female red Australian cattle dog
from Jerez (New Mexico) was presented on June 2013
with a history of a chronic waxing/waning episcleral mass
in the left eye, which was firm on palpation (Figure 4A).
The animal was heartworm antigen negative and wastreated with doxycycline (5 mg/kg orally twice daily), anti-
biotics and corticosteroids. One week after the presen-
tation, the owner reported that rapid and significant
response to the medical therapy was achieved, with
complete resolution of the episcleral mass. Therefore, the
anti-inflammatory and antibiotic treatment was suspended
six weeks after the presentation. Six months later, the
episcleral mass reoccurred and the animal was taken to
surgery (Figure 4B). At time of surgery, the animal under-
went the same therapeutic protocol and recheck examina-
tions of case 4 and 5 and, one month after, complete
resolution of the episcleral mass was noted in the left eye.
However, a generalized episcleritis was recorded in the
right eye, associated with a moderate exophthalmos.
Therefore, a second subconjunctival exploratory was per-
formed in the right eye and multiple nematodes were ex-
tracted. The animal was treated as in the cases above. A
last follow up three months after surgery revealed
complete resolution of the ocular alterations.
Case 8
A 5-year-old neutered male German shepherd dog from
Farmington (New Mexico) was presented on April 2011
due to chronic conjunctivitis in the left eye. Ophthalmic
findings revealed a large flocculent episcleral mass in the
left eye, occupying the entirety of the ventral episcleral
mass and extending distally past the equatorial portion
of the globe. The animal was diagnosed with keratocon-
junctivitis sicca (KCS) but was heartworm antigen nega-
tive. A subconjunctival exploratory surgery was then
performed and several thread-like nematodes were re-
moved from the left eye. The animal was treated as in
the cases above, along with tacrolimus (0.03% in both
eyes, twice daily) to address the KCS and was monthly
rechecked for a period of four months. One year follow-
ing the last monthly recheck examination, the dog dis-
played recurrence of conjunctivitis in the left eye,
exhibiting moderate chemosis of the ventral bulbar
Figure 4 Ophthalmic examination of dog 4. Episcleral nodule (A) and nematodes extracted during the incisional biopsy (B). Two weeks post
surgery follow-up with complete resolution of the ocular condition (C).
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was performed but no nematodes were detected. Monthly
recheck examinations were performed for a period of three
months. At each of these rechecks moxydectin was admin-
istered (0.22 mg/kg subcutaneously). Additional postopera-
tive therapy was doxycycline, doxycycline (5 mg/kg orally
twice daily for three months) and neopolydex in both eyes,
three times daily. Following monthly recheck examinations
and the final moxydectin injection, prophylactic oral anthi-
helmintic therapy with ivermectin was initiated at 400 μg/
kg orally every day for 30 days and recommended for life.
The dog remained disease free.
Morphological and molecular identification
Specimens presented external round transverse ridges and
two transverse striae per each outer ridge interval, with a
typical body diameter/ridge distance interval of 7–10:1
[27]. The nematode morphology and the sequencing of
barcoding genes of parasites obtained from cases 2 and 3
were concordant in identifying the specimens recovered
from all cases herein reported as O. lupi. In addition, a
100% nucleotide sequence homology was recorded be-
tween pcox1 [26] and 12S rDNA sequences herein ob-
tained (AN: KP283474 and KP283475) and those of
specimens collected from dogs and cats from different
states within the United States (cox1: JX080028- JX080031,
JF758473-JF758475, KC763785-KC763786; 12S rDNA:
KC763783).
Discussion
Data reported provide new information on the clinical
presentation of O. lupi infection in dogs. Along withdata in the literature (Table 1; Figure 5), results confirm
that O. lupi is widespread in the United States. Indeed,
all previous descriptions of canine onchocercosis caused
by unidentified Onchocerca species [12,17-19], may be
attributed to O. lupi due to the site of the infection (i.e.,
ocular tissues), which is peculiar to this nematode, and
to a retrospective analysis of the geographical origin of
the infections. For example, O. lupi has been diagnosed
in Palmdale, California [20], which is situated only
12 km away from the municipality of Lancaster where a
case of Onchocerca sp. was previously documented [19].
Consequently, the epidemiology of O. lupi in the United
States deserves to be thoroughly assessed since it is likely
more widely distributed than currently believed. Indeed,
all the reports above were characterized by nodular le-
sions, but, in the only large epidemiological study per-
formed in Portugal and Greece, where clinical cases were
reported, up to 8.4% of the examined animals scored posi-
tive for O. lupi microfilariae [11]. Certainly, a serological
tool for the diagnosis of O. lupi [28] would overcome the
difficulties related with the detection of microfilariae in
the skin snip biopsy, which is an invasive procedure and of
limited usefulness during the prepatent period of the in-
fection. Today, the skin-snip for the detection of skin-
dwelling microfilariae is the most sensitive procedure for
the diagnosis in asymptomatic dogs. This tool should be
used for screening dogs relocated from endemic areas,
such as New Mexico, to other regions.
Cases herein reported were characterized by a similar
clinical presentation, which included subconjunctival
and episcleral nodules. In addition, all dogs examined
were adults (from three to nine years of age), which may
Table 1 Canine onchocercosis in the USA: review of cases described in the literature and present report, along with
data on the geographical origin, location of lesions and diagnosis
Sex (Age in years) Geographic origin (Travel) Localization of the nodule (eye) Diagnosis Reference in
the text
Female (15) California Sclera (OD, then OS) Onchocerca sp. [17]
Female (10) Los Angeles, California Sclera Onchocerca sp. [18]
Male (9) Utah Conjunctiva, Sclera (OS, then OD) Onchocerca sp. [18]
Male (adult) Phoenix, Arizona Free worm in the cornea Onchocerca lienalis [19]
Female (1) Lancaster, California Retrobulbar space (OD) Onchocerca lienalis [19]
Male (6) California Sclera Onchocerca sp. [12]
Male (10) California (Washington, Idaho, Nevada) Sclera (OS) Onchocerca sp. [12]
Male (adult) Palmdale, California Conjunctiva Onchocerca lupi [20]
Male (adult) Las Vegas, Nevada - Onchocerca lupi [20]
Male (adult) Mancos, Colorado Conjunctiva Onchocerca lupi [20]
Male (adult) Kanab, Utah - Onchocerca lupi [20]
Male (7) Oronoco, Minnesota (Durango, Colorado) Conjunctiva (OU) Onchocerca lupi [26]
Female (6) Englewood, Colorado (New Mexico) Sclera (OS) Onchocerca lupi [26]
Female (2) Englewood, Colorado (Farmington, New Mexico) Sclera (OU) Onchocerca lupi [26]
Male (3) Farmington, New Mexico Conjunctiva (OU) Onchocerca lupi [26]
Male (3) Farmington, New Mexico Sclera (OD) Onchocerca lupi [26]
Female (9) Jemez, New Mexico Sclera (OS, then OD) Onchocerca lupi [26]
Male (5) Farmington, New Mexico Sclera (OS, relapsing) Onchocerca lupi [26]
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fection is usually long [9], as already described for O. volvu-
lus (i.e., up to 18 months) [2]. The negative results obtained
with the heartworm antigen tests suggest that commercial
kits used for screening D. immitis infection are not able to
detect cross-reactions with O. lupi. Accordingly, since
some of the dogs herein examined underwent chemo-
prophylactic treatment for the canine heartworm disease
with ivermectin, this therapy is most likely ineffective
against O. lupi. Indeed, to date the only treatment with
reputed efficacy for ocular onchocercosis is represented
by the surgical removal of the parasitic nodule followed
by post-operative therapeutic administration of melar-
somine (2.5 mg/kg intramuscularly, daily for two days),Figure 5 Distribution of canine onchocercosis in the USA. Blue diamonivermectin (50 μg/kg subcutaneously, one month after the
initial treatment), topical antibiotics and systemic prednis-
olone [12,14]. The above pharmaceutical treatment has
been successfully applied to control the relapse of nodules
up to more than one year of follow-up. However, al-
though Wolbachia endosymbionts were detected in O.
lupi [10,15,29] any chemoprophylactic combination of
tetracyclines with macrocyclic lactones has never been
tested. Indeed, the use of doxycycline targeting the
Wolbachia endosymbionts of filariae was effective in
damaging and even killing D. immitis adult worms [30]
and succeeded in eliminating adults of D. immitis,
eventually reducing the risk of thromboembolism [31,32].
Similarly, a combination of doxycycline hyclate (10 mg/kgds indicate new cases of Onchocerca lupi infection.
Otranto et al. Parasites & Vectors  (2015) 8:89 Page 7 of 8twice daily for 30 days) and ivermectin (6 μg/kg every
15 days for six months) was effective for treating microfi-
lariaemia in dogs affected by D. repens, a cause of subcuta-
neous dirofilariosis [33].Conclusion
Data herein reported indicate that O. lupi may be a risk
for human health. Along with the human case reported
from Arizona [21], other cases of human onchocercosis
have been diagnosed in Arizona, Colorado, Minnesota
and Pennsylvania [21,34]. Therefore, further studies are
urgently needed in order to improve the diagnosis of O.
lupi infection infection, to better define its pathogenesis,
and to report the efficacies of therapeutic protocols,
based on controlled clinical trials. These studies should
target the parasite itself and/or its endosymbionts.
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